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Introduction
Minimally invasive parathyroidectomy (MIP) 
has recently replaced the gold standard of bilat-
eral neck exploration (BNE) in the surgical treat-
ment of most patients with sporadic primary hy- 
 perparathyroidism (pHPT) [1–6]. Minimally inva- 
sive parathyroidectomy focuses on resecting an 
image-indexed solitary parathyroid adenoma 
through a short skin incision, without a need for 
intraoperative identification and assessment of 
the remaining glands; intraoperative intact para-
thyroid hormone (IOPTH) assay is often used in-
stead to confirm cure of the hyperparathyroid 
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A b s t r a c t
Introduction: Minimally invasive parathyroidectomy (MIP) with intraoperative parathyroid hormone assay (IOPTH) 
has successfully replaced conventional neck exploration in most patients with primary hyperparathyroidism (pHPT) 
and preoperatively localized parathyroid adenoma. 
Aim: To compare outcomes of video-assisted MIP (MIVAP) to open MIP (OMIP).
Material and methods: A retrospective case-controlled study of 455 patients with sporadic pHPT undergoing MIP 
with IOPTH at our institution in 2003–2012 was undertaken. The primary outcome measure was postoperative 
pain. Secondary outcome measures were: duration of surgery, recurrent laryngeal nerve (RLN) identification rate, 
conversion rate, length of hospital stay, cure rate, patients’ satisfaction with cosmetic outcome, morbidity, costs, and 
diagnostic accuracy of IOPTH.
Results: Of 455 patients with pHPT and a solitary parathyroid adenoma on preoperative imaging, 151 underwent 
MIVAP and 304 had OMIP. The following outcomes were favourable for MIVAP vs. OMIP: lower pain intensity during 
24 h postoperatively (p < 0.001), lower analgesia request rate (p < 0.001), lower analgesics consumption (p < 0.001), 
higher recurrent laryngeal nerve identification rate (p < 0.001), shorter scar length (p < 0.001), and better cosmetic 
satisfaction at 1 month (p = 0.013) and at 6 months (p = 0.024) after surgery. However, MIVAP vs. OMIP had longer 
duration of surgery (p < 0.001), and was more expensive (p < 0.001). No differences were noted in the conversion 
rate, length of hospital stay, and morbidity. 
Conclusions: Both MIVAP and OMIP approaches were equally safe and effective. However, the outcomes of MIVAP 
operations were superior to OMIP in terms of lesser postoperative pain, lower analgesics consumption, and better 
cosmetic satisfaction resulting from a smaller scar. 
Key words: minimally invasive parathyroidectomy, minimally invasive video-assisted parathyroidectomy, open mini-
mally invasive parathyroidectomy, intraoperative parathyroid hormone assay.
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state. Among fundamental advantages of MIP – 
besides better cosmetic effects and less pain – is 
a  significant decrease in the percentage of post-
operative transient hypoparathyroidism, which 
drops to approximately 5–10% as compared to 
some 20–25% following BNE, as well as complete 
elimination of the risk of permanent hypoparathy-
roidism. This results from preserving intact the 
blood supply of the remaining, normal parathy-
roid glands, which are not exposed during MIP. In 
turn, a lower transient hypocalcaemia percentage 
after MIP is associated with a significantly lower 
demand for calcium and vitamin D3 preparations 
and shorter hospitalisation, whereas the success 
rate of this technique in restoring normal calcium 
levels in expert hands of endocrine surgeons ex-
ceeds 98% [2, 5]. Among the presently employed 
methods of MIP, the most commonly selected 
techniques include minimally invasive video as-
sisted parathyroidectomy (MIVAP) developed by 
Miccoli [7, 8], Udelsmann’s open minimally inva-
sive parathyroidectomy (OMIP) [9, 10], Gagner’s 
endoscopic parathyroidectomy using the central 
approach [11, 12], the same procedure, but per-
formed from the lateral approach, as described by 
Henry [1, 13], or else parathyroidectomy guided by 
a gamma-probe [14]. Which of these approaches is 
superior remains an open question [6, 15]. Many 
endocrine surgeons recommend that the treat-
ment of choice for solitary parathyroid adenoma 
should be OMIP, due to advantages in operative 
duration, a  shorter learning curve and improved 
cost-effectiveness [6]. Unfortunately, the few 
hitherto published randomized controlled trials 
comparing different minimally invasive surgical 
approaches for removal of a  solitary parathyroid 
adenoma were explanatory rather than pragmatic 
trials due to the small number of patients involved 
[16, 17]. Thus, from the clinical viewpoint, it is im-
portant to validate outcomes of these explanatory 
trials in large cohort studies. To address this is-
sue, we performed a retrospective case-controlled 
analysis comparing outcomes of the two MIP tech-
niques most commonly utilized at our institution, 
MIVAP and OMIP, among a large series of patients 
operated on within the last decade.
Aim
The aim of this study was to compare outcomes 
of MIVAP to OMIP.
Material and methods
Study design and patient selection
This was a  retrospective cohort study of pa-
tients who underwent MIP for sporadic pHPT at 
the Third Department of General Surgery, Jagiello-
nian University Medical College, Krakow, Poland. 
The prospectively collected database of parathyroid 
surgery was searched for eligible patients (treated 
in 2003–2012). All the patients provided written 
informed consent for the storage and use of their 
data. Of 610 patients meeting the inclusion crite-
ria who were identified in the register, 460 patients 
were eligible for MIP. The inclusion criteria for MIP 
were: biochemically confirmed sporadic primary hy-
perparathyroidism, suspicion of a single parathyroid 
adenoma localized by at least one imaging examina-
tion (ultrasound of the neck and/or 99mTc-MIBI sub-
traction scintigraphy), adenoma size as confirmed by 
ultrasonography not exceeding 30 mm in the largest 
diameter and absence of any concomitant thyroid 
pathology that would require surgical treatment. 
The exclusion criteria from MIP were: past surgery 
involving the neck, history of cervical irradiation, in-
cluding 131I therapy, multinodular goitre or suspected 
thyroid carcinoma, suspected multiglandular para-
thyroid disease, familial hyperparathyroidism and 
suspected MEN syndrome, as well as incomplete 
clinical data or follow-up information. Five of 460 
eligible patients refused to undergo MIP and under-
went conventional BNE. Finally, 455 patients (398 
females and 57 males) underwent MIP and were in-
cluded in the study. The study group comprised pa-
tients who underwent MIVAP. They were compared 
to patients who had OMIP. The type of initial para-
thyroid exploration (MIVAP vs. OMIP) was based in 
the majority of cases on a patient’s choice (395/455 
= 86.8%), following a  detailed discussion with all 
patients undergoing initial parathyroid exploration 
for apparent sporadic pHPT. However, the initial se-
ries of patients (60/455 = 13.2%) reported in this 
cohort was randomly assigned to MIVAP or OMIP 
intervention at a 1 : 1 ratio [16]. All the patients had 
preoperatively biochemically confirmed pHPT and 
laryngoscopy. Table I  presents clinical and patho-
logical characteristics of the study patients. All the 
patients qualified for MIP had parathyroid imaging 
with at least two modalities: neck ultrasound and 
subtraction parathyroid scintigraphy, or SPECT-CT 
with 99mTc-MIBI involving the neck and superior 
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mediastinal region (Orbiter, Siemens, Erlangen, Ger-
many), evaluated by a  nuclear medicine specialist 
experienced in parathyroid imaging. Neck ultraso-
nography was performed using a  7.5–15 MHz lin-
ear-array transducer by a  surgeon experienced in 
parathyroid imaging. The primary outcome measure 
was postoperative pain. Secondary outcome mea-
sures were: duration of surgery, recurrent laryngeal 
nerve identification rate, conversion rate, length of 
hospitalisation, cure rate, patients’ satisfaction with 
cosmetic outcome, morbidity and costs. In addition, 
diagnostic accuracy of IOPTH in prognostication of 
cure of hyperparathyroidism was evaluated in the 
entire cohort of patients. The protocol of this study 
was approved by the Institutional Review Board.
Surgical technique
All operations were performed under general 
anaesthesia by one of two endocrine surgeons in-
volved, with each performing a  similar number of 
respective interventions (p = 0.678). The MIVAP 
procedures were performed employing the Miccoli 
technique (Photo 1) [7, 8]. The patients were placed 
in the same position as required in classic thyroid 
surgery, but hyperextension of the neck was avoided 
in order not to decrease the working space beneath 
the short muscles of the platysma. A  1.5 cm-long 
horizontal section was made approximately 2 cm 
above the sternal notch. The short muscles of the 
platysma were longitudinally dissected into layers 
in the midline and the working space was bluntly 
Table I. Clinical and pathological characteristics of patients in the study
Parameter MIVAP (n = 151) OMIP (n = 304) Value of p
Gender, n (%): 0.075
Female 138 (91.4) 260 (85.5)
Male 13 (8.6) 44 (14.5)
Age, mean ± SD (range) [years] 51.7 ±14.9 (18–75) 57.7 ±16.3 (18–82) < 0.001
BMI, mean ± SD (range) [kg/m2] 27.2 ±4.5 (19.2–35.0) 27.3 ±4.8 (19.4–35.7) 0.838
Total serum calcium level, mean ± SD (range) [mmol/l] 2.95 ±0.16 (2.69–3.21) 3.02 ±0.19 (2.69–3.65) < 0.001
iPTH serum level, mean ± SD (range) [ng/l] 257.5 ±97.2 (101.1–421.5) 280.0 ±105.7 (110.2–860.4) 0.028
Creatinine, mean ± SD (range) [µmol/l] 86.1 ±15.7 (65–116) 87.9 ±15.0 (63–117) 0.238
Alkaline phosphatase, mean ± SD (range) [IU/l] 130.5 ±27.0 (37–230) 140.3 ±36.7 (39–239) 0.231
Pathology, n (%): 0.709
Single parathyroid adenoma 147 (97.3) 294 (96.7)
Double parathyroid adenoma 3 (2.0) 9 (3.0)
Four-gland parathyroid hyperplasia 1 (0.7) 1 (0.3)
Parathyroid cancer 0 (0.0) 0 (0.0)
Adenoma weight, mean ± SD (range) [g] 1.97 ±1.46 (0.25–4.68) 2.30 ±1.65 (0.48–5.69) < 0.001
Localization of the parathyroid adenoma, n (%): 0.737
Right superior 35 (23.3) 74 (24.4)
Right inferior 40 (26.7) 82 (27.1)
Left superior 37 (24.7) 74 (24.4)
Left inferior 41 (27.3) 82 (27.1)
Disease, n (%): 0.089
Symptomatic 104 (68.9) 232 (76.3)
Asymptomatic 47 (31.1) 72 (23.7)
BMI – body mass index, iPTH – intact parathyroid hormone. Reference ranges: total calcium (2.2–2.6 mmol/l), iPTH (12–65 ng/l), creatinine (60–120 μmol/l), 
total alkaline phosphatase (30–260 IU/l)
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dissected manually between the thyroid gland and 
the muscles, avoiding pneumoperitoneum. A 5 mm 
30-degree endoscope was introduced into the inci-
sion, and the working space was maintained using 
2–4 conventional retractors to retract the thyroid 
lobe medially towards the trachea and the muscles 
laterally towards the cervical vessels, thus exposing 
the thyroid sulcus. The tissues were dissected using 
microsurgical instruments, mostly a suction spatula 
and a  dissector. Videoscopic magnification signifi-
cantly facilitated identification of the cervical ana-
tomical structures, including the recurrent laryngeal 
nerve. Having exposed the adenoma of the parathy-
roid, the surgeon performed a blunt resection, exer-
cising caution not to damage the capsule and thus 
risking implantation of disseminated parathyroid 
cells. Following the exposure of the vascular pedi-
cle of the parathyroid gland, it was electrocauterized 
by bipolar coagulation. The adenoma was delivered 
through the main surgical incision, which was sub-
sequently closed with loose single stitches, followed 
by closing the skin with intracutaneous absorbable 
sutures. No wound drainage was employed. The ma-
terial was sent for histopathology. At the same time, 
the surgeon waited for the result of IOPTH determi-
nation.
In the OMIP procedures, the surgical technique 
relied on the method developed by Irvin and modi-
fied by Udelsmann (Photo 2) [9, 10, 18]. A 2–3 cm-
long skin incision (a short Kocher incision) was made 
in the majority of patients above the jugular notch. 
In adenomas of the superior parathyroids or situ-
ated outside the oesophagus, the skin incision was 
made somewhat more superiorly, along the anterior 
margin of the sternocleidomastoid muscle. Having 
dissected laterally into layers the short muscles of 
the platysma, the thyroid lobe was mobilized; the 
adenoma was identified, resected and sent for his-
topathology, with the surgeon waiting for the result 
of IOPTH determination. Routinely, the exposure of 
the other parathyroid gland situated on the ipsilat-
eral (operated on) side of the neck was avoided. The 
wound was closed loosely and no wound drainage 
was employed.
Photo 1. Minimally invasive video assisted parathyroidectomy. A, B – A 5 mm rigid endoscope and all work-
ing instruments are inserted into the neck through one small incision above the sternal notch. C – Working 
space is created by blunt dissection and maintained by retractors without gas insufflation. D – Intraoper-
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Intraoperative iPTH assay
IOPTH determinations were routinely performed 
in all MIP operations using the STAT-Intraopera-
tive-iPTH-Assay (Future Diagnostics, Wijchen, The 
Netherlands). Blood samples were collected from 
a  Venflon catheter inserted into the basilic vein. 
Three ml of blood were collected in an EDTA vacuum 
test tube. The specimens were collected according 
to the following protocol: 1) preoperatively, after 
anaesthesia induction but before incising the skin; 
2) after exposing and dissecting free the parathy-
roid adenoma, immediately before its resection; 
3) 10 min following the adenoma resection. To as-
sess the effectiveness of the procedure and to pre-
dict postoperative normocalcaemia, the modified 
Miami criterion was employed (a decrease in serum 
parathyroid hormone concentration by more than 
50% at 10 min) following adenoma resection as 
compared to the higher of the two values describ-
ing the parathyroid hormone level prior to surgery or 
prior to adenoma resection [19]. In cases not meet-
ing the Miami criterion, an additional determination 
was made 20 min following adenoma resection, 
and if no decrease in parathyroid hormone concen-
tration was observed, the procedure was extended 
to unilateral and bilateral neck exploration [20]. All 
IOPTH determinations were performed within the 
operating suite complex. A  single determination 
required 8 min. Intraoperative histopathology was 
used in selected patients.
Postoperative follow-up
Pain intensity was assessed by an independent 





Photo 2. Open minimally invasive parathyroidectomy. A – Conventional approach for parathyroid adenoma 
during bilateral neck exploration through the Kocher incision. B, C – In the OMIP approach, a small skin 
incision is made directly over the preoperatively image-indexed parathyroid lesion. D – Intraoperative view 
of the superior left parathyroid adenoma delivered over the skin incision
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(VAS) at 4, 8, 12, and 24 h postoperatively. The pa - 
tients were aware that the scale analysed the in-
tensity of pain alone and was not a  representa-
tion of their generalized postoperative discomfort. 
Nurse-controlled analgesia rate (NCA) on the pa-
tient’s request, as well as analgesics consumption, 
was recorded for 24 h postoperatively. Ketoprofen 
(Sandoz, Poland) was used as a painkiller, the dose 
being 50 mg administered on demand (not more 
frequently than every 6 h). Duration of surgery 
was calculated from skin incision to skin closure. 
Conversion from MIP to unilateral neck exploration 
was used in cases not meeting the modified Miami 
criterion of IOPTH [19, 20]. In cases of intraopera-
tive demonstration of a normally appearing second 
parathyroid gland on the operated side or of un-
successful unilateral neck exploration in converted 
patients, BNE was performed. Total serum calcium 
concentration values at 24 and 48 h postoperative-
ly were routinely measured. If serum calcium lev-
els dropped below 2 mmol/l, oral supplementation 
with calcium preparations was administered, along 
with vitamin D metabolites. Cure of hyperparathy-
roidism was defined as postoperative normocal-
caemia lasting for at least 6 months after surgery. 
Hypercalcaemia within 6 months postoperatively 
signified persistent disease, whereas hypercalcae-
mia after more than 6 months following surgery 
denoted recurrent disease. Hypocalcaemia was de-
fined as total serum calcium level below 2.0 mmol/l 
irrespectively of iPTH level. A  serum calcium level 
below 2.0 mmol/l with a  subnormal serum iPTH 
level (< 10 ng/l) was defined as transient hypopara-
thyroidism if restored to normal within 12 months 
following withdrawal of oral calcium or calcium 
plus calcitriol therapy. Persistent hypocalcaemia 
with serum iPTH level below 10 ng/l for more than 
12 months postoperatively, requiring substitution 
with calcium with or without calcitriol, was con-
sidered permanent hypoparathyroidism. Indirect 
laryngoscopy was used to identify and follow RLN 
injury (on postoperative day 1, and in cases of vo-
cal fold paresis, every 2 months within 1 year af-
ter surgery, or until the vocal folds recovery). The 
nerve events incidence was calculated based on 
the number of nerves at risk. Patients’ satisfaction 
with the cosmetic result of the procedure (based on 
the Verbal Rating Scale (VRS); 0 – poor, 1 – weak, 
2 – satisfactory, 3 – good, 4 – very good, 5 – excellent) 
including scar length and healing was assessed at 
1, 6 and 12 months postoperatively during outpa-
tient follow-up visits. Cost analysis was performed 
using an official in-hospital price list for medical 
procedures. The costs included (in EUR): 20 EUR for 
ultrasonography, 200 EUR for sestamibi scintigra-
phy, 100 EUR for IOPTH, 5 EUR/min for anaesthesia, 
5 EUR/min for operating theatre use, 5 EUR/min for 
videoscopic equipment, and 80 EUR/day of hospi-
talisation.
Statistical analysis
For sample size calculation, an assumption was 
made that MIVAP should result in pain intensity low-
er by 30% as compared to OMIP. To detect this, it 
was calculated that 124 patients would be required 
in each treatment arm to give the study a power of 
95%. Anticipating a 15% loss to follow-up, 150 pa-
tients per arm were required in the study.
Data are presented as mean with standard de-
viation (SD) or range, unless stated otherwise. The 
statistical significance of categorical variables was 
evaluated by the χ2 test, whereas Student’s t test 
was used for analysis of continuous variables. Re-
ceiver operating characteristics (ROC) were used to 
evaluate the diagnostic accuracy of IOPTH in prog-
nostication of cure of the hyperparathyroid state. All 
the data were collected prospectively and stored in 
a computer-based institutional register of parathy-
roid surgery and analysed retrospectively by a stat-
istician. Statistical analyses were performed with 
MedCalc (version 13, MedCalc Software, Belgium). 
Value of p < 0.05 was considered to indicate a sig-
nificant difference.
Results
Of 1107 patients referred for parathyroid sur-
gery during the study interval, 690 had pHPT and 
were potential candidates for the study. Two-hun-
dred and twenty-seven patients did not meet the 
inclusion criteria (negative or discordant preopera-
tive imaging 65; concomitant goitre necessitating 
surgical removal 51; persistent pHPT 50; recurrent 
pHPT 22; MEN 1 syndrome 17; lithium treatment 
12; lacking consent for MIP 5; MEN 2A syndrome 5), 
and 8 had incomplete histopathology or follow-up 
data, leaving 455 patients who were finally included 
in this study. 
One-hundred and fifty-one patients underwent 
MIVAP, whereas 304 patients underwent OMIP. 
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There were 398 women and 57 men with a mean 
age at operation of 55.7 ±16.1 years (range: 18–82). 
Analysis of baseline characteristics identified that 
MIVAP patients were significantly younger (51.7 
±14.9 years vs. 57.7 ±16.3 years, respectively; p < 
0.001), had lower total serum calcium levels (2.95 
±0.16 mmol/l vs. 3.02 ±0.19 mmol/l, respectively; p < 
0.001), lower preoperative serum iPTH levels (257.5 
±97.2 ng/l vs. 280.0 ±105.7  ng/l, respectively; p = 
0.028) and smaller adenomas (1.97 ±1.46 g vs. 2.30 
±1.65 g, respectively; p < 0.001) than OMIP patients. 
Despite concordant results of preoperative imaging 
in all the patients in this cohort, a solitary parathy-
roid adenoma was found in 441 (96.9%) patients, 
whereas 14 (3.1%) patients had multiglandular dis-
ease (double adenoma 12, four-gland hyperplasia 2). 
Table I  shows clinical and pathological characteris-
tics of patients analysed in this study.
Primary outcome
Pain assessed by VAS was significantly lower at 
4, 8, 12, and 24 h postoperatively in MIVAP versus 
OMIP patients, respectively (p < 0.001). The differ-
ence in pain intensity varied between the groups, 
being 22.6% at 4 h, 7.3% at 8 h, 25.2% at 12 h, and 
32.7% at 24 h after surgery. The analgesia request 
rate was significantly lower in MIVAP versus OMIP 
patients (65.6% vs. 91.4%, respectively; p < 0.001). 
Mean analgesics consumption was also lower 
among MIVAP compared with OMIP patients (48.0 
±41.6 mg vs. 89.1 ±48.9 mg of ketoprofen, respec-
tively; p <0.001). Detailed data are shown in Table II.
Secondary outcomes
Mean operative time was significantly longer 
for MIVAP vs. OMIP operations (42.5 ±10.1 min vs. 
37.4 ±10.9  min, respectively; p < 0.001). The RLN 
identification rate was significantly higher in the 
MIVAP vs. OMIP group (92.7% vs. 72.7%, respective-
ly, p < 0.001). Scar length was significantly shorter 
in the MIVAP vs. OMIP group (17.8 ±1.9 mm vs. 31.4 
±4.2 mm, respectively; p < 0.001). Patients’ satisfac-
tion with cosmetic outcome assessed by VRS was 
significantly higher after MIVAP vs. OMIP, both at 
1 month (3.77 ±0.62 vs. 3.60 ±0.75 points, respec-
tively; p = 0.013) and at 6 months (4.10 ±0.71 vs. 
3.95 ±0.70 points, respectively; p = 0.024) postop-
eratively. Mean hospitalisation costs were higher in 
the MIVAP group compared with the OMIP group for 
total hospital charges, but the difference was related 
to the higher costs of endoscopic tools involvement 
and longer operating time, both being independent-
ly charged 5 EUR each per minute of operation, with 
the mean difference being 207.7 EUR. Thus, MIVAP 
was on average 25% more expensive than OMIP.
Non-significant differences were observed be-
tween both groups in cure rate, length of hospital-
isation and morbidity. Details are shown in Table II. 
ROC analysis identified the following diagnostic ac-
curacy of the modified Miami criterion employed 
for IOPTH interpretation in prognostication of cure 
of hyperparathyroidism: sensitivity 97.7%, specific-
ity 96.4%, positive predictive value 99.8%, negative 
predictive value 73.0%, and overall accuracy 97.6%.
Discussion
This retrospective case-controlled study com-
pared outcomes of video-assisted vs. open MIP and 
suggested a  similar cure rate of the hyperparathy-
roid state, but lower pain intensity within 24 post-
operative hours, lower analgesia request rate, lower 
analgesics consumption, improved RLN identification 
rate, shorter scar length and higher cosmetic satis-
faction rate after video-assisted parathyroidectomy. 
However, all these benefits were achieved in the MI-
VAP group at higher costs than in the OMIP group, 
mainly due to the need for use of endoscopic tools. 
Similar outcomes were initially reported by our group 
in a small (n = 60) randomized study, and now have 
been confirmed in a large cohort (n = 455) of patients 
with sporadic pHPT treated in 2003–2012. However, 
somewhat conflicting outcomes were reported by 
Hessman et al., with 143 patients randomized to 
undergo video-assisted vs. open MIP. In this study, 
surgery duration was significantly shorter for open 
compared to video-assisted MIP (60 ±35 min vs. 84 
±47 min, respectively; p = 0.001), but both groups of 
patients had similar conversion rates and the same 
outcome, with comparable incision lengths, low 
scores for postoperative neck discomfort, high cos-
metic satisfaction and low complication rates [17]. 
A  possible explanation of the differing outcomes 
found in these two studies is the mixed type of in-
tervention in the video-assisted arm in the Hessman 
et al. study, as patients underwent either MIVAP ac-
cording to the Miccoli technique or video-assisted 
parathyroidectomy using a lateral approach (VAPLA) 
according to the Henry technique [17].
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Minimally invasive parathyroidectomy has gained 
worldwide acceptance in the surgical treatment of 
sporadic pHPT, replacing the gold standard of BNE in 
patients with a presumed solitary parathyroid ade-
noma [1–6]. Recent advances in parathyroid imaging 
allow for highly accurate pre-selection of patients 
with pHPT for MIP, whereas IOPTH can be used to 
monitor intraoperatively the quality of surgery, min-
imizing the risk of overlooking multiglandular dis-
ease [21–23]. As expressed in a  survey distributed 
among members of the International Association of 
Endocrine Surgeons (IAES), MIP is currently offered 
to patients by almost two-thirds of endocrine sur-
geons worldwide [24]. There are many different MIP 
techniques (open, video-assisted or endoscopic), 
but regardless of the technique, all these minimal-
Table II. Primary and secondary outcomes
Parameter MIVAP (n = 151) OMIP (n = 304) Value of p
Postoperative pain (VAS), mean ± SD (range) [pts]
At 4 h 22.3 ±4.6 (15–30) 28.8 ±5.8 (19–38) < 0.001
At 8 h 25.3 ±5.0 (17–34) 27.3 ±5.7 (18–37) < 0.001
At 12 h 16.6 ±4.1 (10–25) 22.2 ±4.9 (14–30) < 0.001
At 24 h 10.9 ±3.7 (5–18) 16.2 ±3.8 (10–22) < 0.001
Analgesia request, n (%) 99 (65.6) 278 (91.4) < 0.001
Analgesics consumption, mean ± SD (range) [mg] 48.0 ±41.6 (0–150) 89.1 ±48.9 (0–200) < 0.001
Duration of surgery, mean ± SD (range) [min] 42.5 ±10.1 (25–60) 37.4 ±10.9 (20–55) < 0.001
RLN identification, n (%) 140 (92.7) 221 (72.7) < 0.001
Conversion, n (%): 4 (2.7) 10 (3.3) 0.709
UNE 1 (0.7) 4 (1.3)
BNE 3 (2.0) 6 (2.0)
Length of hospital stay, mean ± SD (range) [days]: 1.14 ±0.48 (1–3) 1.20 ±0.51 (1–3) 0.216
1 day, n (%) 138 (91.4) 258 (84.9)
2 days, n (%) 5 (3.3) 31 (10.2)
3 days, n (%) 8 (5.3) 15 (4.9)
Cure of hyperparathyroidism, n (%) 150 (99.3) 303 (99.7) 0.613
Length of scar, mean ± SD (range) [mm] 17.8 ±1.9 (15–21) 31.4 ±4.2 (25–38) < 0.001
Patients’ satisfaction with cosmetic outcome (VRS), mean ± SD (range) [pts]:
At 1 month 3.77 ±0.62 (2–5) 3.60 ±0.75 (1–5) 0.013
At 6 months 4.10 ±0.71 (2–5) 3.95 ±0.70 (2–5) 0.024
Morbidity, n (%): 0.627
Transient hypocalcaemia 7 (4.6) 16 (5.3)
Permanent hypoparathyroidism 0 (0.0) 0 (0.0)
Transient RLN injury 2 (1.3) 5 (1.6)
Permanent RLN injury 1 (0.7) 3 (1.0)
Costs, mean (range) [EUR] 1048.7 (775.0–1460.0) 841.0 (600.0–1110.0) < 0.001
VRS – verbal rating scale (0 – poor, 1 – weak, 2 – acceptable, 3 – good, 4 – very good, 5 – excellent), SD – standard deviation, RLN – recurrent laryngeal nerve, 
UNE – unilateral neck exploration, BNE – bilateral neck exploration
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ly invasive operations share the same philosophy of 
the image-guided selective removal of a single para-
thyroid adenoma [23]. Thus, it is not surprising that 
all these techniques have a similar success rate in 
correcting the hyperparathyroid state. On the other 
hand, many soft endpoints can be different and in-
fluence postoperative recovery. 
The primary outcome of this study was postop-
erative pain assessed by VAS and it was found to be 
significantly lower in MIVAP versus OMIP patients at 
all evaluated time points within the initial 24 post-
operative hours. The reason for this could not have 
been entirely related to the shorter skin incision in 
MIVAP versus OMIP patients (17.8 ±1.9 mm vs. 31.4 
±4.2  mm, respectively; p < 0.001) and less tissue 
damage. In fact, postoperative pain is also caused 
by neck hyperextension, which is avoided in the 
video-assisted technique [7, 8]. Mean differences in 
pain intensity varied from 22.6% at 4 h to 32.7% at 
24 h postoperatively (p < 0.001). The benefit of lower 
postoperative pain in the MIVAP group was also con-
firmed by a lower analgesia request rate (p < 0.001) 
and reduced analgesics consumption (p < 0.001).
Both the MIVAP and OMIP techniques were safe, 
as the prevalence of RLN injury was not significant-
ly different between the groups. However, in MIVAP 
patients, the RLN identification rate was significant-
ly higher than in OMIP patients (92.7% vs. 72.7%, 
respectively; p < 0.001). 
Theoretically, during OMIP, the tissues are subject-
ed to a higher degree of traction, which may increase 
the risk of transient RLN injury. It can also be hypo-
thesized that the video-assisted technique pro-
vides magnification of the dissected structures (up to 
10 times), allowing for easier recognition of the nerve. 
But even in the most experienced hands, nerve events 
still occur in about 1% of patients, irrespectively of the 
intraoperative neural monitoring use. 
In addition, MIVAP patients experienced signifi-
cantly higher cosmetic satisfaction with their scars 
(the scars being significantly shorter than in OMIP 
patients). This was true for 1 and 6 months after sur-
gery, and cosmetic satisfaction tended to increase 
with time in both groups. Similar observations were 
made among 240 patients undergoing minimally in-
vasive video-assisted thyroidectomy (MIVAT) at our 
institution [25, 26]. No differences were observed in 
the mean length of hospitalisation. Although over-
night hospitalisation was mandatory due to the re-
imbursement-associated insurer’s regulations, both 
procedures could have been successfully performed 
in the majority of non-complicated cases as outpa-
tient operations under local anaesthesia [10, 27]. 
Mean hospital stay costs were significantly higher in 
the MIVAP compared with the OMIP group, and the 
difference was related mostly to the charges for en-
doscopic tool involvement, and marginally to some-
what longer surgery duration, whereas all other com-
ponents, including localization studies, were similar.
A  clearly identifiable bias in this study is that 
type of initial parathyroid exploration (MIVAP vs. 
OMIP) was based in the majority of individuals on 
a  patient’s choice, following a  detailed discussion 
of potential advantages and disadvantages of each 
technique. Surprisingly, only one-third of patients 
preferred MIVAP, whereas the remaining two-thirds 
were in favour of OMIP. Patients who gave their 
consent for MIVAP were younger (p < 0.001), had 
lower serum calcium levels (p < 0.001), lower serum 
iPTH levels (p = 0.028), and lower adenoma weight 
(p < 0.001) than their OMIP counterparts (details are 
shown in Table I). Despite these statistically signifi-
cant differences in baseline characteristics of both 
groups, they can be considered marginal from a clin-
ical viewpoint, allowing for a fair comparison of both 
techniques evaluated in this study. Melck et al. found 
similar differences when comparing 125 video-as-
sisted MIP cases with 95 open MIP control subjects. 
In this study, patients undergoing OMIP had higher 
mean preoperative levels of calcium (p = 0.007) and 
parathyroid hormone (p = 0.008), greater mean ad-
enoma weight (p < 0.001), and increased long-term 
mortality (4% OMIP vs. 0% MIVAP, p = 0.03) [28]. 
The main concerns voiced by adversaries of MIP 
address the risk of recurrent hyperparathyroidism 
becoming evident in the late postoperative period 
[29, 30]. For many years, the incidence of multiglan-
dular disease in patients subjected to BNE was es-
timated at approximately 15–22% (chiefly on the 
basis of the macroscopic criterion, i.e. the size of the 
parathyroid glands), whereas after MIP, the corre-
sponding rate is only 4–5% [31]. On the one hand, 
this phenomenon results from pre-selection of pa-
tients qualified for MIP based on imaging studies, 
but on the other, it is a consequence of the parathy-
roid size not always correlating with the function of 
the gland. The concern about a higher risk of recur-
rent hyperparathyroidism after MIP seems unwar-
ranted, since in the most extensive investigations, 
the follow-up period is longer than 10 years. West-
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erdahl et al. observed only sporadic cases of hyper-
parathyroidism recurrence in patients operated on 
in their young age, who were later diagnosed with 
type I MEN syndrome [32]. Among our patients with 
the mean follow-up of 42.7 ±15.8 months (range: 
12–112 months), we noted one case of recurrent hy-
perparathyroidism (the menin gene mutation) diag-
nosed 36 months postoperatively. Moreover, Schnei-
der et al. retrospectively reviewed a series of 1368 
parathyroid operations for primary hyperparathy-
roidism performed within the last decade. A total of 
1006 were MIP whereas 380 were OP. There were no 
differences in recurrence between the MIP and OP 
groups (2.5% vs. 2.1%; p = 0.68), and the operative 
approach (MIP vs. OP) did not independently predict 
recurrent disease in the multivariable analysis [30].
Finally, it should be noted that the MIP procedure, 
in spite of its simplicity, might not be recommended 
as the method of choice performed in each and ev-
ery surgical ward in view of the possible lack of one 
or several key elements of this operation. The most 
important component of MIP is the surgeon experi-
enced in parathyroid surgery. The surgeon should not 
attempt employing the MIP method while operating 
on the parathyroids until he gains expertise in classic 
BNE procedures. Secondly, availability of high-level 
imaging techniques, such as subtraction scintigraphy 
or high-resolution ultrasonography, is necessary to 
properly preselect patients qualified for MIP. Thirdly, 
availability of IOPTH is needed to minimize the risk of 
missing multiglandular disease in patients with false 
positive results of imaging examinations [33–35]. 
Whether the differences in pain intensity, analge-
sics consumption and improved cosmetic satisfac-
tion are sufficient to compensate for the additional 
costs of endoscopic tool involvement will depend on 
local circumstances – the healthcare system and the 
acceptance of improved cosmetic outcomes as the 
leading benefits of the video-assisted MIP approach 
[16]. However, in most healthcare centres, the treat-
ment of choice can be OMIP, due to advantages in 
operative duration, a  short learning curve and im-
proved cost-effectiveness [6].
Conclusions
Both MIVAP and OMIP approaches were equally 
safe and effective in surgical treatment of patients 
with sporadic primary hyperparathyroidism. How-
ever, outcomes of MIVAP operations were superior 
to OMIP in terms of lesser postoperative pain, lower 
analgesics consumption, and better cosmetic satis-
faction resulting from a  smaller scar. Nevertheless, 
a  video-assisted procedure is more expensive and 
requires experience not only in parathyroid surgery, 
but also in endoscopic surgery, as well as availability 
of appropriate endoscopic instruments. 
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